Skip To Main Content
David Krug on Muck Rack

David Krug

As seen in: Nature, Wiley Online Library, MDPI, The Lancet, EIN News, EIN Presswire, 901am, Newstrail

Get in touch with David

Contact David, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Challenges and strategies for delivering effective breast cancer care in conflict zones

|
By Nader Hirmas, Johannes Holtschmidt, Stephan Falk, Ernst Hanisch, Carsten Denkert, Jörg Heil, Thomas A. Decker, David Krug, Sibylle Loibl
| Nature Verified
Abstract Breast cancer remains the most frequently diagnosed cancer among women worldwide, and its burden is particularly severe in regions affected by conflict and war. In these settings, oncology care is often disrupted by the destruction of healthcare infrastructure, displacement of populations, shortages of trained personnel, and limited access to diagnostics and treatment.
Open in Who Shared Issue with article?

Partial-breast irradiation: has the dust finally settled?

|
By David Krug, Jürgen Dunst, David Kruga
| The Lancet Verified
References 1. Kirby, AM ∙ Finneran, L ∙ Griffin, CL ∙ et al. Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial Lancet Oncol. 2025; 2. Goldberg, M ∙ Bridhikitti, J ∙ Khan, A ∙ et al. Meta-analysis of trials of partial breast irradiation Int J Radiat Oncol Biol Phys. 2023; 115:60-72 3.
Open in Who Shared Issue with article?

Partial-breast irradiation: has the dust finally settled?

|
By David Krug, Jürgen Dunst, David Kruga
| The Lancet Verified
FREE with registration! Log in or register to access the full article. References 1. Kirby, AM ∙ Finneran, L ∙ Griffin, CL ∙ et al. Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial Lancet Oncol. 2025; 2. Goldberg, M ∙ Bridhikitti, J ∙ Khan, A ∙ et al. Meta-analysis of trials of partial breast irradiation Int J Radiat Oncol Biol Phys.
Open in Who Shared Issue with article?
See all 167 articles